SE400076B - Forfarande for framstellning av 5-(3-substituerade amino-2-hydroxipropoxi)-1,3-disubstituerade pyrazolforeningar vilka uppvisar beta-adrenergiskt blockerande egenskaper - Google Patents

Forfarande for framstellning av 5-(3-substituerade amino-2-hydroxipropoxi)-1,3-disubstituerade pyrazolforeningar vilka uppvisar beta-adrenergiskt blockerande egenskaper

Info

Publication number
SE400076B
SE400076B SE7305383A SE7305383A SE400076B SE 400076 B SE400076 B SE 400076B SE 7305383 A SE7305383 A SE 7305383A SE 7305383 A SE7305383 A SE 7305383A SE 400076 B SE400076 B SE 400076B
Authority
SE
Sweden
Prior art keywords
proproxy
hydroxy
procedure
preparation
substituted amino
Prior art date
Application number
SE7305383A
Other languages
English (en)
Swedish (sv)
Inventor
B K Wasson
C S Rooney
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of SE400076B publication Critical patent/SE400076B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • C07D231/22One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28Two oxygen or sulfur atoms
    • C07D231/30Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7305383A 1972-05-05 1973-04-16 Forfarande for framstellning av 5-(3-substituerade amino-2-hydroxipropoxi)-1,3-disubstituerade pyrazolforeningar vilka uppvisar beta-adrenergiskt blockerande egenskaper SE400076B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA141470A CA1001161A (en) 1972-05-05 1972-05-05 5-(3-substituted amino-2-hydroxypropoxy)1,3-disubstituted pyrazoles and method of preparation

Publications (1)

Publication Number Publication Date
SE400076B true SE400076B (sv) 1978-03-13

Family

ID=4093188

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7305383A SE400076B (sv) 1972-05-05 1973-04-16 Forfarande for framstellning av 5-(3-substituerade amino-2-hydroxipropoxi)-1,3-disubstituerade pyrazolforeningar vilka uppvisar beta-adrenergiskt blockerande egenskaper

Country Status (14)

Country Link
US (1) US3920691A (pt-PT)
JP (1) JPS4947367A (pt-PT)
AU (1) AU474793B2 (pt-PT)
BE (1) BE799098A (pt-PT)
CA (1) CA1001161A (pt-PT)
CH (1) CH582677A5 (pt-PT)
DE (1) DE2322313A1 (pt-PT)
ES (1) ES414320A1 (pt-PT)
FR (1) FR2183751B1 (pt-PT)
GB (1) GB1390485A (pt-PT)
HU (1) HU165583B (pt-PT)
NL (1) NL7305477A (pt-PT)
SE (1) SE400076B (pt-PT)
ZA (1) ZA733049B (pt-PT)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2619164C2 (de) * 1976-04-30 1985-07-11 Boehringer Mannheim Gmbh, 6800 Mannheim Indazolyl-(4)-oxy-propanolamine, Verfahren zu ihrer Herstellung und deren Verwendung
FI57617C (fi) * 1979-01-18 1980-09-10 Viljanmaa Antti Spaennanordning foer skinn
DE2926517A1 (de) * 1979-06-30 1981-01-15 Beiersdorf Ag Substituierte 3-aryl-pyrazole und 5-aryl-isoxazole und verfahren zu ihrer herstellung
US5547967A (en) * 1993-12-08 1996-08-20 Kali-Chemie Pharma Gmbh (Phenylalkylaminoalkyloxy)-heteroaryl-compounds, processes and intermediates for their production and pharmaceutical compositions containing them
DE4341749A1 (de) * 1993-12-08 1995-06-14 Kali Chemie Pharma Gmbh 3-(Phenylalkylaminoalkyloxy)-5-phenylpyrazol- Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
WO1999029672A1 (en) * 1997-12-05 1999-06-17 Eli Lilly And Company SELECTIVE β3 ADRENERGIC AGONISTS
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1201061A (en) * 1966-08-26 1970-08-05 Endo Lab Oxo pyrroles and process for preparing same
US3629433A (en) * 1968-09-16 1971-12-21 Ciba Geigy Corp Antidepressant compositions of cycloalkano(c)pyrazole ethers
US3637738A (en) * 1969-02-12 1972-01-25 Ciba Geigy Corp Cycloalkano(c)pyrazole ethers
US3726896A (en) * 1970-05-06 1973-04-10 Szabo Hnos Kessler & Cia 1-benzyl-3(2,3-dihydroxypropoxy)indazole

Also Published As

Publication number Publication date
AU5493773A (en) 1974-10-31
FR2183751B1 (pt-PT) 1976-10-22
HU165583B (pt-PT) 1974-09-28
CA1001161A (en) 1976-12-07
AU474793B2 (en) 1976-08-05
ZA733049B (en) 1974-12-24
NL7305477A (pt-PT) 1973-11-07
ES414320A1 (es) 1976-02-01
US3920691A (en) 1975-11-18
DE2322313A1 (de) 1973-11-22
FR2183751A1 (pt-PT) 1973-12-21
JPS4947367A (pt-PT) 1974-05-08
BE799098A (fr) 1973-11-05
GB1390485A (en) 1975-04-16
CH582677A5 (pt-PT) 1976-12-15

Similar Documents

Publication Publication Date Title
SE7506819L (sv) Forfarande for framstellning av substituerade 1,2,4-triazolderivat
DK133672B (da) Analogifremgangsmåde til fremstilling af imidazolderivater.
NO138532C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-(4-fenoksy-fenyl)-1,3,5-triazin-derivater
FI55194B (fi) Foerfarande foer framstaellning av 6-substituerade 4-amino-1,2-dihydro-1-hydroxi-2-iminopyrimidiner
SE381047B (sv) Forfarande for framstellning av 3-substituerade 1,2-bensisoxazolderivat
AR206214A1 (es) Procedimiento para la preparacion de nuevos compuestos derrivados de 1-(4-substituido)-fenoxi-2-hidroxi-3-amino propano
NO147916C (no) Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser.
SE400076B (sv) Forfarande for framstellning av 5-(3-substituerade amino-2-hydroxipropoxi)-1,3-disubstituerade pyrazolforeningar vilka uppvisar beta-adrenergiskt blockerande egenskaper
IT974512B (it) Procedimento per la preparazione di composti immino eterociclici
SE7608958L (sv) Forfarande for framstellning av 2-(fenoxialkyl-sulfinyl eller -sulfonyl) imidazoler
SE398120B (sv) Forfarande for framstellning av 3-(1-piperazinylalkyl)-2,4-kinazolindionforeningar
SE408709B (sv) Forfarande for framstellning av indol-, resp azaindol merkatoforeningar
SE416201B (sv) Foerfarande foer framstaellning av 1,4-bensodiazepinderivat
SE397085B (sv) Forfarande for framstellning av 2-(6'-karbalkoxihexyl)-4(r)-hydroxicyklopentan-1,3-dioner
NO142669C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, heterocykliske forbindelser
SE410458B (sv) Forfarande for framstellning av vissa angivna 1,2,4-triazolderivat
SE387940B (sv) Forfarande for framstellning av stereoisomerer av 1-(1-(-kloorbensyl)-2'-pyrryl)-2-disek, butylaminoetanol
DK135042B (da) Analogifremgangsmåde til fremstilling af 3,5-disubstituerede triazolderivater.
DK127297B (da) Analogifremgangsmåde til fremstilling af heterocyclisk substituerede nebularinderivater.
SE410315B (sv) Forfarande for framstellning av pyrazolderivat
AR219897A1 (es) Procedimiento para la preparacion de 1-sustituido, 5-(fenil) sustituido)-3-metil-1,3,5-triazapenta-1,4-dieno
SE405853B (sv) Forfarande for framstellning av 2-kinoxalinkarboxamid-1,4-dioxider
SE408302B (sv) Forfarande for framstellning av 1,4-bensodiazepin-derivat
SE384506B (sv) Analogiforfarande for framstellning av 1-(polyfluoralkyl)-1,4-bensodiazepin-2-tioner
DK426576A (da) Fremgangsmade til fremstilling af 1-alkyl-3,5-disubstituerede 1,2,4-triazolderivater